You are here

Drugmakers court fight underscores high stakes in haemophilia

Zurich

ROCHE'S bid to muscle in on Shire's share of the US$11 billion haemophilia drug market took a new, contentious turn this weekend when the British drugmaker won a court injunction against how the Swiss drugmaker talks about its new medicine.

Shire's injunction on Sunday in a

sentifi.com

Market voices on:

Editor's Choice

Powered by GET.comGetCom